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Achalasia is an esophageal motility disorder characterized by increased lower
esophageal sphincter pressure and absence ofperistalsis in the loweresophagus.
Patients typically present with complaints of progressive difficulty swallowing
over a period of several years. Diagnosis is confirmed by esophageal manome-
try. Complications of achalasia include esophagitis, aspiration and possibly an
increased risk of esophageal carcinoma. Medical treatment options include
pneumatic dilatation, esophageal bougienage, nitrates, calcium channel block-
ers and botulinum toxin injections. The primary method ofsurgical treatment is
the Heller myotomy, in which longitudinal incisions are made in the muscle
fibers of the lower esophageal sphincter to reduce sphincter pressure.
Frequently, a fundoplication is performed in addition to the myotomy to
decrease the likelihood ofdevelopment ofgastroesophageal reflux.
In recent years, the Heller myotomy has been performed both thoracoscopical-
ly and laparoscopically. An additional development has been the placement of
an endoscope in the esophagus to provide transillumination during surgery;
intraoperative endoscopy allows improved assessment ofthe depth ofmyotomy
incisions and reduces the risk ofesophageal perforation. The case report below
describes a 64-year-old-man with achalasia who presented with persistent dys-
phagia despite multiple attempts at medical treatment. A laparoscopic Heller
myotomy with Toupet fundoplication was performed with subsequent eradica-
tion of symptoms. A discussion of the epidemiology, etiology, clinical presen-
tation, diagnosis and treatment ofachalasia follows the case report.
INTRODUCTION
Achalasia is an esophageal motility disorder characterized by three abnormalities of
smooth muscle function: (1) failure of the lower esophageal sphincter to relax complete-
ly following deglutition, (2) normal to increased lower esophageal sphincter pressure and
(3) absence ofperistaltic contractions in the esophageal body [1]. The most common clin-
ical manifestation of achalasia is dysphagia, which may be accompanied by chest pain.
Treatment ofthis condition involves disruption ofnon-relaxing smooth muscle in the area
of the lower esophageal sphincter.
A case of severe achalasia and its treatment in a 64-year-old man is presented below.
CASE REPORT
G.W. is a 64-year-old white male who presented to the GI surgical service at Yale
New Haven Hospital for evaluation of difficulty swallowing. At that time, the patient
described progressive difficulty swallowing over the seven-month period prior to admis-
sion. He stated that this dysphagia was most pronounced when he attempted to swallow
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solids. The patient had initially been able to swallow liquids successfully and had been
drinking nutritional supplements; more recently, he had begun experiencing dysphagia
with liquids as well and reported regurgitating solidified beverages.
Upon the recommendation ofhis internist, the patient consulted a gastroenterologist.
Five months prior to admission, a barium swallow, endoscopy and esophageal manome-
try were performed. The barium swallow demonstrated severe distal esophageal narrow-
ing. The endoscopy demonstrated normal mucosa without evidence of neoplasm or any
obstructive intraluminal masses. Manometry revealed a loweresophageal sphincter (LES)
pressure of 33 mm Hg (normal LES pressure ranges from 10 to 20 mm Hg) as well as
absent peristalsis in the distal esophagus. Contractions occurred simultaneously through-
outthe distal esophagus and were oflow amplitude. Thepatient was diagnosed with acha-
lasia on the basis of his clinical presentation and the above findings.
Esophageal balloon dilatations wereperformed three times within the six-month peri-
od prior to admission. The patient reported temporary decreases in dysphagia but stated
that the difficulty swallowing returned within days to weeks following each episode of
dilatation.
The patient reported a twelve pound weight loss since six months prior to admission.
He denied loss ofappetite and any gastrointestinal complaints other than difficulty swal-
lowing. One month prior to admission, he was offered treatment options including further
balloon dilatation, therapy with botulinum toxin or elective surgical myotomy. After con-
sideration, the patient chose the surgical procedure. Following discontinuation of
coumadin (the patient had been taking coumadin since a pulmonary embolism one year
prior), the patient was admitted for IV heparin therapy. After cessation of heparin, he
underwent a laparoscopic Heller myotomy and Toupet partial fundoplication. These pro-
cedures were performed via five separate laparoscopic port sites using a 30-degree angle
telescope for full visualization of the region of the esophagogastric (EG) junction.
Intraoperative endoscopy was performed during the myotomy, which permitted precise
control of gastric insufflation and transillumination of the myotomy site. A 270-degree
fundoplication was created, and seven sutures were used to secure the two fundal compo-
nents of the wrap to the edges of the myotomy. At the conclusion of the myotomy, the
mucosabulged freely along its entire length, which extended 5 cm proximal and 2 cm dis-
tal to the EGjunction (Figure 1). Thepatient's post-operative course was remarkable only
for an episode ofangina accompanied by T wave inversions on ECG. The patient's ECG
reverted to normal, and he did not have a significant increase in cardiac enzymes. He
began eating a soft diet on post-operative day two and was discharged to home on post-
operative day four. At follow-up two weeks later, the patient was eating a normal diet
without difficulty. He reported occasional heartburn symptoms, which were controlled by
daily administration of an H2 receptor antagonist.
DISCUSSION
Epidemiology
Achalasia is a rare disorder with an incidence ofless than one per 100,000 people per
year in the USA, and there is no definite sex or race predilection [2]. The relative contri-
bution of genetic and environmental factors toward the development of achalasia is
unclear. Previous suggestions of autosomal recessive inheritance remain unsubstantiated
[3]. A large retrospective study of hospitalizations for achalasia demonstrated geographi-
cal variation in the frequency ofachalasia among Medicare patients, with high rates in the
South and low rates around the Great Lakes and the Pacific U.S. [2].
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Figure 1. Bulging, transilluminated mucosa withinmyotomy between anterior vagus nerve (A)
and retracted left crus ofdiaphragmatic hiatus ofesophagus (B).
Etiology
Achalasia appears to result from esophageal denervation; histological examination of
tissue from patients with achalasia demonstrates degenerative changes in the ganglion
cells of the myenteric plexus, the dorsal motor nucleus of the vagus nerve and the fibers
ofthe vagus nerve itself[4]. In addition, inflammatory.changes with lymphocytic infiltra-
tion are also evidentin association with themyenteric plexus [5]. Impairment ofrelaxation
ofthe LES is probably due to decreased function of nerves that inhibit contraction of the
sphincter. The neurotransmitters involved most likely include nitric oxide and vasoactive
intestinal peptide [6]. The etiology ofthe neuronal degeneration in patients with achalasia
is unknown; hypotheses include damage secondary to infection with a virus such as vari-
cella zoster or an autoimmune process [5].
Clinical Presentation
Achalasia is usually characterized by an indolent course; symptoms are present for an
average of seven years before medical help is sought [4]. The most common presenting
symptom is dysphagia, which is present in 82 percent to 100 percent of patients [4, 7].
This dysphagia may be intermittent, may occur with ingestion of solids, liquids, or both,
and usually becomes progressively worse over time [7]. Regurgitation of stagnant, undi-
gested food occurs in 56 to 94 percent ofpatients [4] and can cause aspiration with noc-
turnal cough, pneumonia or lung abscesses. Chest pain occurs in 50 percent of patients;
achalasia is diagnosed in 10 percent ofpatients with noncardiac chest pain. The pain may
be caused by esophageal dilation proximal to the LES, esophagitis or esophageal spasms
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[8]. In one series, heartburn was reported in 44 percent ofpatients with achalasia [9]. This
substernal burning discomfort is purported to be secondary to fermentation of static food
in the esophagus by bacteria rather than by gastroesophageal reflux [10]. Furthermore,
weight loss is also often a presenting symptom of achalasia. Weight loss can occur as a
result of inadequate esophageal emptying in addition to decreased intake due to fear of
dysphagia and chest pain.
Previously, achalasia has been discussed in terms of two distinct entities: classic and
vigorous achalasia. Patients with relatively high amplitude esophageal contractions were
said to have vigorous achalasia, which was thought to be associated with chest pain. A ret-
rospective study performed in 1991, which compared radiographic and clinical findings as
well as response to balloon dilatation in patients with classic and vigorous achalasia, did
not find any significant difference between the two groups [11]. The distinction has been
utilized less frequently in recent years.
Diagnosis
Esophageal manometry represents the gold standard for diagnostic confirmation of
achalasia. Manometric evaluation of esophageal pressure in patients with achalasia typi-
cally demonstrates normal peristaltic contractions in the upper esophagus. The distal
esophagus exhibits low amplitude contractions, which occur simultaneously rather than in
a peristaltic wave pattern. In addition, the LES shows a failure of relaxation and often a
high resting pressure. The LES resting pressure is usually elevated to about 35 mm Hg
(normal, 10 to 20 mm Hg) [7].
Barium esophagrams ofpatients with achalasia typically demonstrate a "bird's beak"
appearance of the distal esophagus at the region of esophageal narrowing, and a dilated
esophagus resembling the sigmoid colon is often seen proximally [12]. Chest radiographs
can show a widened mediastinum due to esophageal dilation, an air-fluid level in the pos-
terior mediastinum due to stasis of swallowed food and liquid in the esophagus and the
absence of a gastric air bubble (50 percent ofpatients) [12].
Endoscopy of the upper GI tract in patients with achalasia is usually unremarkable
but is mandatory in patients being evaluated for achalasia in order to exclude pseudoacha-
lasia (achalasia secondary to malignancy). Malignancy represents the most ominous ofthe
various causes ofsecondary achalasia, which include amyloidosis, Chagas' disease, MEN
IIb and familial adrenal insufficiency [12]. Malignancy can produce achalasia through a
number of mechanisms, including direct invasion of the myenteric plexus and ganglion
cells by tumor, damage to the vagus nerve by tumor or a paraneoplastic neuropathy not
involving direct neuronal invasion by tumor [12]. There are three clinical findings that
should raise suspicion ofa responsible malignancy in a patient with achalasia ofunknown
origin: onset of symptoms after age 60, presence of symptoms for less than one year and
weight loss of more than twenty pounds [4].
Complications
The complications associated with achalasia are, for the most part, secondary to food
stasis. Retained food and fluid in the esophagus creates a hospitable environment for bac-
terial or candidal infection, producing esophagitis. Stasis also frequently results in aspira-
tion, which can lead to pneumonia or lung abscesses, as stated above. In addition, the
chronic presence of static food in the esophagus is thought to contribute to an increased
incidence of esophageal carcinoma in patients with achalasia. A large-scale population-
based study conducted in Sweden demonstrated a sixteen-fold increase in the risk of
esophageal cancer (primarily squamous cell carcinoma) in patients with, compared to
patients without, achalasia [13]. An additional complication of achalasia is the develop-
ment ofepiphrenic diverticula secondary to increased intraesophageal pressure.
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Treatment
Medical treatment ofachalasia has been directed at decreasing LES pressure in order
to improve esophageal emptying and prevent stasis-related complications. The most fre-
quently used non-surgical treatment method is pneumatic dilatation, which consists of
rupturing LES sphincter fibers by passing a balloon dilator through the LES and inflating
the balloon. Studies examining the overall efficacy of a course of treatment of balloon
dilatation in the long-term reversal of symptoms of achalasia have demonstrated clinical
improvement in approximately 70 percent ofpatients [4]. The majority ofpatients do not
obtain lasting relief from the symptoms of achalasia after a single episode of balloon
dilatation; in one study, only 20 percent ofpatients exhibited a decrease in LES pressure
and a return of peristalsis following the initial dilatation [14]. However, repeated dilata-
tions produced a response in a greater number ofpatients. Results were better in patients
over age 45 who had experienced symptoms for more than five years. The complications
associated with pneumatic dilatation include esophageal perforation, which occurs in two
to 10 percent of patients [4, 15]. Less commonly, aspiration pneumonia, localized
hematoma, or esophageal tear without perforation occur. Finally, reflux esophagitis was
reported as occurring in one to seven percent of patients following balloon dilatation in
studies conducted in the 1980s [16-18]; a' more recent study questioned the validity of
these earlierresults and suggested thatheartburn symptoms and esophagitis in post-dilata-
tion patients could be due to impaired esophageal clearing rather than reflux [19].
Other nonsurgical methods for the treatment of achalasia include esophageal
bougienage, which usually results only in temporary relief from dysphagia and is rarely
used. Pharmaceutical intervention is more common: nitrates and calcium channel block-
ers have been used with some success to decrease LES pressure in patients with achalasia
[1]. More recently, botulinum toxin, which inhibits the release ofacetylcholine from nerve
terminals, has been injected directly into the LES to induce relaxation ofthe sphincter by
decreasing excitatory cholinergic innervation to the sphincter muscle. Early studies
demonstrated that treatment with botulinum toxin is safe and effective in the short term.
In one prospective study, intrasphincteric administration of botulinum toxin produced a
decrease in symptoms associated with achalasia in two-thirds of patients for a period of
approximately 16 months following initial treatment [20]. However, patients who choose
intrasphincteric botulinum injections as their mode of therapy require endoscopy on a
nearly annual basis; furthermore, the long-term safety and efficacy ofrepeated botulinum
toxin injections has not been evaluated.
Patti et al. conducted a prospective study comparing patients receiving pneumatic
dilatation, pharmacotherapy with calcium channel blockers, or both, with patients receiv-
ing surgical treatment (myotomy via a thoracoscopic approach) [22]. Treatment results
were assessed by telephone interviews with patients every three months for a mean peri-
od of 28 months after therapy. Results were classified according to the following schema:
"Excellent" signified no dysphagia; "Good" indicated less than one episode ofdysphagia
per week; "Fair" meant more than one episode ofdysphagia per week; and "Poor" repre-
sented persistent dysphagia. Within the group receiving medical treatment, 26 percent of
patients had "Excellent" or "Good" responses to medical treatment (all of those patients
had undergone balloon dilatation at least once), and 74 percent had "Fair" to "Poor"
responses. In the surgical group, 87 percent ofpatients had "Excellent" or "Good" results,
and the remaining 13 percent had "Fair" or "Poor" responses to treatment [22].
The mainstay ofsurgical treatment for achalasia is the Heller myotomy, in which the
muscle fibers of the LES are destroyed by longitudinal incisions. The myotomy extends
from approximately 5 to 7 cm above the LES to several centimeters below the EGjunc-
tion (the appropriate lower border of the myotomy remains subject to debate), and the
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mucosa and submucosa bulge outward from the lumen following the full-thickness divi-
sion ofesophageal muscle fibers [21]. The procedure was firstdescribedby Hellerin 1914
and initially required either a laparotomy or a thoracotomy; more recently, the Heller
myotomy has been performed via a laparoscopic or thoracoscopic approach with an asso-
ciated decrease in length of hospital stay and post-procedural morbidity. In one study
comparing laparoscopic versus open Heller-Dor procedures, the median postoperative
hospital stay was fourdays following laparoscopy and 14 days following laparotomy. The
median time elapsed before patients returned to normal activity was 10 days after the
laparoscopic procedure and 30 days after the open procedure [24]. One disadvantage of
minimal access approaches is the absence of tactile information available during an open
procedure. The placement of an endoscope in the esophagus during the myotomy allows
better assessment ofthe depth ofthe myotomy and decreased the risk ofperforation ofthe
esophageal wall [22].
Controversy exists regarding the superiority ofthe thoracoscopic or the laparoscopic
approach. Raiser et al. suggest that the laparoscopic approachprovides better access to the
gastric fundus, enabling the surgeon to extend the myotomy further onto the stomach and
decreasing the difficulty ofperforming an anti-reflux procedure [21]. Their study demon-
strated a statistically significant increase in both the duration ofpostoperative hospital stay
and in time elapsed prior to return to normal activity in patients approached thoracoscop-
ically as opposed to laparoscopically. It is also the impression ofthe authors that the trans-
abdominal approach is technically simpler and results in faster recovery than the thoraco-
scopic approach.
The main complication associated with the surgical treatment of achalasia is the
development of gastroesophageal reflux, which occurs in approximately 12 percent of
patients following Heller myotomy [23]. The likelihood ofthe development ofreflux can
be greatly reduced by the concomitant performance of an anti-reflux procedure. The two
most frequently employed procedures are the Dor fundoplication, in which a portion of
the gastric fundus is pulled anteriorly around the esophagus and fixed to the cut edges of
the myotomy, and the Toupet procedure, in which the gastric fundus is wrapped 270
degrees around the esophagus from its posterior aspect and each cut myotomy edge is
fixed to the adjacent portion of the fundus. Raiser et al. compared the Heller-Toupet and
Heller-Dor procedures performed either laparoscopically or thoracoscopically in terms of
post-surgical manometry, pH analysis and clinical course and concluded that the Heller-
Toupet procedure performed laparoscopically was the favored approach to surgical inter-
vention for achalasia [21]. Atlong-term follow up, 33 percent ofpatients who received the
Toupet procedure and 71 percent of patients upon whom the Dor procedure was per-
formed reported some degree of dysphagia; 27 percent of patients described heartburn-
like symptoms following the Toupet procedure compared to 57 percent of patients after
the Dor procedure. Both differences are statistically significant. The discrepancy in rates
of dysphagia following surgery may result from structural differences in the two fundo-
plications: in the Dor procedure, the gastric fundus covers the myotomy site, limiting the
bulging of the mucosa and creating the opportunity for scar formation between the
esophageal mucosa and the fundal wrap. In the Toupet procedure, the myotomy is left
uncovered so the mucosa is free to bulge outward [21].
The patient discussed in this case report presented with the dysphagia, the most com-
mon presenting complaint associated with achalasia. Manometric and radiographic find-
ings were also entirely consistent with the diagnosis of achalasia. His presentation was
atypical in terms of the relatively rapid development of clinically significant symptoms,
which would raise suspicion ofachalasia secondary to malignancy, however pseudoacha-
lasia was ruled out in his case by endoscopic examination. The patient initially received
the most frequently used medical treatment for achalasia, balloon dilatation, but three
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consecutive courses of dilatation did not significantly reduce his symptoms. Surgical
treatment with laparoscopic Heller myotomy andToupet fundoplication was successful at
initial and three-month follow-up in eradicating the patient's dysphagia. The patient did
experience symptoms of heartburn following the procedure, but these were satisfactorily
controlled with daily administration ofcimetidine. This patient's case illustrates the effec-
tiveness of surgical intervention in treating this disease. The questions of when to refer a
patient for surgical treatment and whether surgery represents a superior method of treat-
ing achalasia, are controversial. A subgroup of patients receiving pneumatic balloon
dilatation have very satisfactory outcomes and do not require surgery to address residual
symptoms. Patients requiring multiple non-operative interventions, who have continued
symptoms or incomplete responses, may be considered for transabdominal Heller myoto-
my with an anti-reflux procedure.
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